Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen
Clinical trial NCT02956421 · COMPLETED
Trial details
- NCT number
- NCT02956421
- Sponsor
- Yisheng Biopharma (Singapore) Pte. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-10-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.